Becker D V, Braverman L E, Dunn J T, Gaitan E, Gorman C, Maxon H, Schneider A B, Van Middlesworth L, Wolff J
JAMA. 1984 Aug 3;252(5):659-61.
In the event of a nuclear reactor accident, radioactive materials could be released into the environment: radioisotopes of iodine could constitute a major component of such a release. Upon such exposure, radioiodines could enter the body and accumulate in an unprotected thyroid gland where they would remain for varying periods of time. A number of methods have been proposed to protect those at risk of exposure. Administration of thyroid-blocking agents (such as potassium iodide) to exposed populations could be effective, but their use has raised a number of questions since there are considerable gaps in the scientific information available about the possible effects of low-level radiation from radioiodine. In addition, there are only limited data available about potential toxic side effects of potassium iodide distributed widely to large, unsupervised populations. Concern about these issues led the American Thyroid Association to appoint a committee of its members with special interest and competence in these areas to review the problems in detail and develop an advisory statement on the questions at issue for those to whom this matter might be of concern.
在发生核反应堆事故时,放射性物质可能会释放到环境中:碘的放射性同位素可能是此类释放物的主要成分。在这种暴露情况下,放射性碘可能会进入人体并积聚在未受保护的甲状腺中,它们会在那里停留不同的时间。已经提出了一些方法来保护有暴露风险的人群。向受暴露人群服用甲状腺阻滞剂(如碘化钾)可能会有效,但由于关于放射性碘低水平辐射可能影响的现有科学信息存在相当大的差距,其使用引发了一些问题。此外,关于广泛分发给大量无监督人群的碘化钾潜在毒性副作用的数据也很有限。对这些问题的关注促使美国甲状腺协会任命了一个由对这些领域有特殊兴趣和能力的成员组成的委员会,以详细审查这些问题,并就可能对此事感兴趣的人所关注的问题制定一份咨询声明。